Teo KK - Search Results

1

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G. Yusuf S, et al. Among authors: teo kk. Lancet. 2020 Mar 7;395(10226):795-808. doi: 10.1016/S0140-6736(19)32008-2. Epub 2019 Sep 3. Lancet. 2020. PMID: 31492503 Free PMC article.

2

Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.

Held PH, Teo KK, Yusuf S. Held PH, et al. Among authors: teo kk. Circulation. 1990 Nov;82(5):1668-74. doi: 10.1161/01.cir.82.5.1668. Circulation. 1990. PMID: 2146038 Clinical Trial.

3

Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence.

Teo KK, Yusuf S. Teo KK, et al. Drugs. 1993 Sep;46(3):347-359. doi: 10.2165/00003495-199346030-00002. Drugs. 1993. PMID: 7693427 Review.

4

Critical review of the approaches to the prevention of sudden death.

Yusuf S, Venkatesh G, Teo KK. Yusuf S, et al. Among authors: teo kk. Am J Cardiol. 1993 Nov 26;72(16):51F-58F. doi: 10.1016/0002-9149(93)90963-d. Am J Cardiol. 1993. PMID: 8237830 Review.

5

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials.

Teo KK, Yusuf S, Furberg CD. Teo KK, et al. JAMA. 1993 Oct 6;270(13):1589-95. JAMA. 1993. PMID: 8371471 Review.

6

The gap between reliable evidence and adoption of therapies.

Yusuf S, Teo KK. Yusuf S, et al. Among authors: teo kk. Eur Heart J. 1999 May;20(9):637-8. Eur Heart J. 1999. PMID: 10419343 No abstract available.

7

Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE).

Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. Anand SS, et al. Among authors: teo kk. Lancet. 2000 Jul 22;356(9226):279-84. doi: 10.1016/s0140-6736(00)02502-2. Lancet. 2000. PMID: 11071182

8

Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).

Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA. Anand SS, et al. Among authors: teo kk. Indian Heart J. 2000 Nov-Dec;52(7 Suppl):S35-43. Indian Heart J. 2000. PMID: 11339439

9

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.

Teo KK, Yusuf S, Pfeffer M, Torp-Pedersen C, Kober L, Hall A, Pogue J, Latini R, Collins R; ACE Inhibitors Collaborative Group. Teo KK, et al. Lancet. 2002 Oct 5;360(9339):1037-43. doi: 10.1016/s0140-6736(02)11138-x. Lancet. 2002. PMID: 12383982 Review.

10

Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.

Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S; HOPE Investigators. Teo KK, et al. Circulation. 2004 Sep 14;110(11):1413-7. doi: 10.1161/01.CIR.0000141729.01918.D4. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353497 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page